ATTACHMENT F
Survey Invitations and Reminder /Letters for Second Survey
All letters will be printed on NIH letterhead or sent from an NIH e-mail address
Letter 1: Initial recruitment letter for second survey, sent to all who responded to initial survey
FirstName LastName
Organization
Address
City, State Zip
Dear Ms/Mr. [NAME],
Last year, you participated in an important survey on HIV vaccine research. Thank you so much for your response. This year, the National Institute on Allergy and Infectious Diseases (NIAID) at the National Institutes of Health (NIH) is requesting that you provide some follow-up information about the same subject. As before, this study seeks guidance from people working in communities that are disproportionately affected by HIV/AIDS. You were selected because of your association with [organization].
As you know, your knowledge and opinions are very important to this study. Your answers will be combined with answers from other respondents, and the resulting summary will be used to guide NIAID programs related to biomedical HIV prevention research. Survey data may also be published in journals that will inform public policy.
As before, your answers to this survey will be kept private to the extent permitted by law; neither NIAID, staff from the NIAID HIV Vaccine Research Education Initiative, nor your employer will be informed of your answers, and all information will be maintained securely according to best practices for data security and privacy. Your answers will be stored separate from your identity, and reports based on survey data will involve information combined across all respondents; individual respondents will never be identified through reports or publications.
It will take about 20 minutes to complete this online survey, found at [Insert Survey URL].
In appreciation for your efforts, at the end of the survey, we will provide a code good for an immediate purchase of $25 at Amazon.com.
If you would prefer to complete the survey on paper or by telephone, please e-mail projectmanager@novaresearch.com, or call (301) ###-####.
If you have any questions or comments regarding this study, please contact the study’s Project Director, Dan Eckstein at 301-986-1891 or deckstein@novaresearch.com, or e-mail me at NHVREIMail@niaid.nih.gov.
Thank you for your valuable assistance with this worthy study.
Sincerely,
Katharine Kripke
Assistant Director, Vaccine Research Program
Division of AIDS, NIAID, NIH
Letter 2: First nonresponse followup letter to individuals that have not completed the second survey
FirstName LastName
Organization
Address
City, State Zip
Dear Ms/Mr. [NAME],
Several weeks ago we sent you an invitation requesting your participation in an important national survey about HIV vaccine research. This survey is a follow-up to one that you completed about one year ago.
If you have already completed this follow-up survey, which is funded by the National Institute of Allergy and Infectious Diseases (NIAID) at the National Institutes of Health (NIH), let me take this opportunity to thank you for your contribution to this vital research.
If you have not yet completed this survey, let me remind you of its importance.
In order to deliver culturally sensitive and effective programs, NIAID relies on input from individuals like you who are working in communities highly impacted by HIV/AIDS. You were selected because of your association with [organization]. Your knowledge and opinions are critical to the guidance of NIAID programs.
Please complete this 20-minute survey related to HIV vaccine research as soon as possible. All of your responses will be kept private to the extent permitted by law, and reports based on survey data will involve information combined across all respondents. At the end of the survey, you will be provided with a coupon worth $25 at Amazon.com.
To take the survey, please go to [Insert survey URL].
If you would prefer to complete the survey on paper or by telephone, please e-mail projectmanager@novaresearch.com, or call (301) ###-####.
If you have any questions or comments regarding this study, please contact the study’s Project Director, Dan Eckstein at 301-986-1891 or deckstein@novaresearch.com, or e-mail me at NHVREIMail@niaid.nih.gov.
Thank you for your valuable assistance with this worthy study.
Sincerely,
Katharine Kripke
Assistant Director, Vaccine Research Program
Division of AIDS, NIAID. NIH
Letter 3: Second nonresponse followup letter to individuals that have not completed the second survey
FirstName LastName
Organization
Address
City, State Zip
Dear Ms/Mr. [NAME],
Over the last several months, we have been trying to reach you about completing an important follow-up survey about HIV vaccine research. You had completed an initial survey for us about one year ago.
We need your help so we can understand the beliefs and attitudes related an HIV/AIDS vaccine in communities disproportionately impacted by the disease. You were selected because of your association with [organization]. The study is funded by the National Institute of Allergy and Infectious Diseases (NIAID) at the National Institutes of Health (NIH). Findings will be used to guide NIAID programs in particular and public policy in general.
If you have already completed this survey, we have not received your data. Please email us at projectmanager@novaresearch.com so we can clear up this issue. We greatly appreciate your assistance, and apologize for any inconvenience.
If you have not yet completed this survey, please take just 20 minutes to fill it out. Without input from people like you who are working in communities that are highly impacted by HIV/AIDS, NIAID’s understanding of how to deliver culturally sensitive and effective programs is incomplete.
All of your responses will be kept private to the extent permitted by law, and at the end of the survey, you will be provided with a coupon worth $25 at Amazon.com.
To take the survey, please go to [Insert survey URL].
If you would prefer to complete the survey on paper or by telephone, please e-mail projectmanager@novaresearch.com, or call (301) ###-####.
If you have any questions or comments regarding this study, please contact the study’s Project Director, Dan Eckstein at 301-986-1891 or deckstein@novaresearch.com, or e-mail me at NHVREIMail@niaid.nih.gov.
Thank you for your valuable assistance with this worthy study.
Sincerely,
Katharine Kripke
Assistant Director, Vaccine Research Program
Division of AIDS, NIAID, NIH
| File Type | application/msword |
| File Title | ATTACHMENT H- E-mail Survey Invitation |
| Author | Allison Zambon |
| Last Modified By | mtuttleman |
| File Modified | 2010-01-20 |
| File Created | 2009-12-17 |